Multi-Omics Analyses Reveal Mitochondrial Dysfunction Contributing to Temozolomide Resistance in Glioblastoma Cells

Huaijin Zhang1, Yuling Chen1, Xiaohui Liu1

  • 1MOE Key Laboratory of Bioinformatics, Center for Synthetic and Systematic Biology, School of Life Sciences, Tsinghua University, Beijing 100084, China.

Biomolecules
|September 28, 2023
PubMed

Insights

Glioblastoma (GBM) treatment resistance can be overcome. Mitochondrial dysfunction and elevated Ca2+ levels contribute to resistance, suggesting combined therapies targeting JNK or STAT3 pathways may improve glioblastoma outcomes.

Area of Science:

  • Neuro-oncology
  • Cancer Biology
  • Mitochondrial Medicine

Background:

  • Glioblastoma (GBM) is an aggressive brain tumor with poor prognosis.
  • Temozolomide (TMZ) is the standard chemotherapy, but resistance limits its effectiveness.

Purpose of the Study:

  • To investigate novel mechanisms of TMZ resistance in GBM.
  • To identify potential therapeutic strategies to overcome TMZ resistance.

Main Methods:

  • Generation of a TMZ-resistant GBM cell line.
  • Multi-omics and energy metabolism analyses.
  • Investigation of the role of mitochondrial dysfunction, calcium levels, and JNK-STAT3 pathway.

Main Results:

  • Mitochondrial dysfunction identified as a novel contributor to TMZ resistance.
  • Rotenone treatment partially induced TMZ resistance.
  • Elevated Ca2+ levels and activated JNK-STAT3 pathway were linked to TMZ resistance.
  • Inhibiting JNK or STAT3 enhanced GBM cell susceptibility to TMZ.

Conclusions:

  • Mitochondrial dysfunction, elevated Ca2+, and JNK-STAT3 pathway activation are key factors in GBM TMZ resistance.
  • Co-administering TMZ with JNK or STAT3 inhibitors shows promise for overcoming treatment resistance in glioblastoma.

Related Concept Videos

Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
18.2K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.1K
Mitochondrial Membranes01:45

Mitochondrial Membranes

A single mitochondrion is a bean-shaped organelle enclosed by a double-membrane system. The outer membrane of mitochondria is smooth and contains many porins - the integral membrane transporters. Porins enable free diffusion of ions and small uncharged molecules through the outer mitochondrial membrane but limit the transport of molecules larger than 5000 Daltons. Further, the outer mitochondrial membrane forms a unique structure called membrane contact sites with other subcellular organelles,...
16.4K